GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for actin-histidine N-methyltransferase (Q5ZML9)

Analyse AlphaFold monomer V2.0 prediction for actin-histidine N-methyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q5ZML9
Type
protein
Length
593 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xd10960F956646DE8b64d3598984c91C2d5Af3D7b
Molecule
Actin-histidine N-methyltransferase
UniProt
Q5ZML9
Pockets
7 · best druggability 0.80

Structure

1 distinct chain · 46% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AActin-histidine N-methyltransferaseprotein59346% helix, 10% strandQ5ZML9

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111610.800.81106empty
21880.490.7624empty
3640.440.8319empty
41200.440.7715empty
5920.390.7718empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.